M. C. Michel

1.1k total citations
34 papers, 921 citations indexed

About

M. C. Michel is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Urology. According to data from OpenAlex, M. C. Michel has authored 34 papers receiving a total of 921 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 11 papers in Cellular and Molecular Neuroscience and 7 papers in Urology. Recurrent topics in M. C. Michel's work include Receptor Mechanisms and Signaling (18 papers), Neuropeptides and Animal Physiology (10 papers) and Urinary Bladder and Prostate Research (7 papers). M. C. Michel is often cited by papers focused on Receptor Mechanisms and Signaling (18 papers), Neuropeptides and Animal Physiology (10 papers) and Urinary Bladder and Prostate Research (7 papers). M. C. Michel collaborates with scholars based in Germany, United Kingdom and Switzerland. M. C. Michel's co-authors include O.‐E. Brodde, H.-R. Zerkowski, H.–R. Zerkowski, A Daul, Otto‐Erich Brodde, Wilhelm Erdbrügger, H. Borst, Willibald Maier, Masaharu Asano and Friedhelm Feth and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, The Journal of Physiology and Pain.

In The Last Decade

M. C. Michel

32 papers receiving 870 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. C. Michel Germany 18 461 256 231 222 143 34 921
Serafim Guimarães Portugal 9 322 0.7× 178 0.7× 171 0.7× 259 1.2× 29 0.2× 20 798
Yvonne Vulliemoz United States 16 443 1.0× 209 0.8× 242 1.0× 258 1.2× 9 0.1× 52 1.0k
J Staszewska-Barczak Australia 12 195 0.4× 265 1.0× 188 0.8× 191 0.9× 10 0.1× 20 779
Z. S. Ercan Türkiye 14 170 0.4× 99 0.4× 106 0.5× 263 1.2× 10 0.1× 82 691
Harold G. Preiksaitis Canada 20 299 0.6× 85 0.3× 156 0.7× 234 1.1× 10 0.1× 28 1.0k
Maria Giuliana Tozzi Ciancarelli Italy 19 149 0.3× 111 0.4× 49 0.2× 238 1.1× 30 0.2× 54 865
Neil G. McKay United Kingdom 17 263 0.6× 134 0.5× 135 0.6× 258 1.2× 253 1.8× 28 1.0k
Koichi Higashimori Japan 18 345 0.7× 700 2.7× 83 0.4× 276 1.2× 6 0.0× 36 1.1k
Xiaolin Deng China 18 186 0.4× 195 0.8× 201 0.9× 255 1.1× 25 0.2× 38 952
Vanhoutte Pm United States 18 249 0.5× 326 1.3× 154 0.7× 411 1.9× 4 0.0× 62 889

Countries citing papers authored by M. C. Michel

Since Specialization
Citations

This map shows the geographic impact of M. C. Michel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. C. Michel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. C. Michel more than expected).

Fields of papers citing papers by M. C. Michel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. C. Michel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. C. Michel. The network helps show where M. C. Michel may publish in the future.

Co-authorship network of co-authors of M. C. Michel

This figure shows the co-authorship network connecting the top 25 collaborators of M. C. Michel. A scholar is included among the top collaborators of M. C. Michel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. C. Michel. M. C. Michel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Michel, M. C., Kurt Miller, Tim Schneider, Christian Ude, & Matthias Oelke. (2025). Characteristics of men using non-prescription medicines to treat their lower urinary tract symptoms. World Journal of Urology. 43(1). 283–283.
2.
Wagg, Adrian, Vikram Khullar, Matthias Oelke, et al.. (2012). 578 Effect of treatment response on the decision to escalate antimuscarinic dose in elderly subjects with overactive bladder. European Urology Supplements. 11(1). e578–e578a. 1 indexed citations
3.
Schneider, Tim, Daniela Marschall‐Kehrel, Jens Ulrich Hanisch, & M. C. Michel. (2010). Do gender, age or lifestyle factors affect responses to antimuscarinic treatment in overactive bladder patients?. International Journal of Clinical Practice. 64(9). 1287–1293. 43 indexed citations
4.
Molderings, G. J., et al.. (2008). Imidazolrezeptoren: Angriffsort einer neuen Generation von antihypertensiven Arzneimitteln: Aktueller Stand und Zukunftsperspektiven. DMW - Deutsche Medizinische Wochenschrift. 117(2). 67–71.
5.
Ohtake, Akiyoshi, Hironori Yuyama, Masashi Ukai, et al.. (2006). Effects of alpha(1)-adrenoreceptor antagonists on pupil diameter and intraurethral pressure in rabbits. Pure Amsterdam UMC. 34. 653–661. 3 indexed citations
6.
7.
Fetscher, Charlotte, et al.. (2001). Modulation of noradrenaline-induced microvascular constriction by protein kinase inhibitors. Naunyn-Schmiedeberg s Archives of Pharmacology. 363(1). 57–65. 14 indexed citations
8.
Goepel, Μ., et al.. (2000). Lack of neuropeptide Y receptor detection in human bladder and prostate. British Journal of Urology. 85(7). 918–924. 13 indexed citations
9.
Bischoff, Angela, et al.. (1997). The Y1 antagonist BIBP 3226 inhibits potentiation of methoxamine-induced vasoconstriction by neuropeptide Y. Naunyn-Schmiedeberg s Archives of Pharmacology. 356(5). 635–640. 15 indexed citations
10.
Chess‐Williams, Russ, et al.. (1996). The effects of SB 216469, an antagonist which discriminates between the α1A‐adrenoceptor and the human prostatic α1‐adrenoceptor. British Journal of Pharmacology. 119(6). 1093–1100. 38 indexed citations
11.
Michel, M. C., et al.. (1994). Sensitization by dexamethasone of lymphocyte cyclic AMP formation: evidence for increased function of the adenylyl cyclase catalyst. British Journal of Pharmacology. 113(1). 240–246. 25 indexed citations
12.
Erdbrügger, Wilhelm, et al.. (1993). Norepinephrine and Neuropeptide Y Increase Intracellular Ca2+ in Cultured Porcine Aortic Smooth Muscle Cells. Journal of Cardiovascular Pharmacology. 22(1). 97–102. 15 indexed citations
13.
Brodde, O.‐E., A Daul, M. C. Michel, & H.–R. Zerkowski. (1992). Bedeutung von β2-Adrenozeptoren bei Herzinsuffizienz. Zeitschrift für Kardiologie. 81(4). 71–78. 4 indexed citations
14.
Feth, Friedhelm, Wolfgang Rascher, & M. C. Michel. (1992). Neuropeptide Y (NPY) receptors in HEL cells: comparison of binding and functional parameters for full and partial agonists and a non‐peptide antagonist. British Journal of Pharmacology. 105(1). 71–76. 33 indexed citations
15.
Michel, M. C., Alan Maisel, & O.‐E. Brodde. (1990). Mitigation of β1- and/or β2-adrenoceptor function in human heart failure. British Journal of Clinical Pharmacology. 30. 10 indexed citations
16.
Tits, Lambertus J.H. van, A Daul, H. Grosse‐Wilde, et al.. (1990). Effects of Insulin-Induced Hypoglycemia onβ2-Adrenoceptor Density and Proliferative Responses of Human Lymphocytes*. The Journal of Clinical Endocrinology & Metabolism. 71(1). 187–192. 9 indexed citations
17.
Brodde, O.‐E., A Daul, & M. C. Michel. (1990). Subtype-selective modulation of human beta 1- and beta 2-adrenoceptor function by beta-adrenoceptor agonists and antagonists.. PubMed. 8 Suppl 2. 11–7. 24 indexed citations
18.
Brodde, Otto‐Erich, H.–R. Zerkowski, H. Borst, Willibald Maier, & M. C. Michel. (1989). Drug- and disease-induced changes of human cardiac  1- and  2-adrenoceptors. European Heart Journal. 10(suppl B). 38–44. 75 indexed citations
19.
Brodde, O.‐E., et al.. (1989).  -adrenoceptor regulation in the human heart: can it be monitored in circulating lymphocytes?. European Heart Journal. 10(suppl B). 2–10. 60 indexed citations
20.
Ikezono, Katsumi, H.–R. Zerkowski, J. J. Beckeringh, M. C. Michel, & O.‐E. Brodde. (1987). Beta-2 adrenoceptor-mediated relaxation of the isolated human saphenous vein.. Journal of Pharmacology and Experimental Therapeutics. 241(1). 294–299. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Serafim Guimarães Breakdown of academic impact, for papers by Yvonne Vulliemoz Breakdown of academic impact, for papers by J Staszewska-Barczak Breakdown of academic impact, for papers by Z. S. Ercan Breakdown of academic impact, for papers by Harold G. Preiksaitis Breakdown of academic impact, for papers by Maria Giuliana Tozzi Ciancarelli Breakdown of academic impact, for papers by Neil G. McKay Breakdown of academic impact, for papers by Koichi Higashimori Breakdown of academic impact, for papers by Xiaolin Deng Breakdown of academic impact, for papers by Vanhoutte Pm
Rankless by CCL
2026